Gastroenterology

Patients knowingly taking inert pills labeled placebo for IBS reported adequate symptom relief, comparable to the most powerful IBS medications.

Engineered Lactobacillus significantly alters fat composition, demonstrating that ingesting live bacteria can influence metabolism all over the body.

Three major medical societies have collaborated to issue recommendations providing guidance on when proton pump inhibitors and clopidogrel can be prescribed.

One out of every 200 patients treated with acid suppressive medication will develop pneumonia according to a recent literature review.

Metabolic alterations may presage small intestinal villous atrophy and rationalize early institution of a gluten-free diet for potential celiac disease.

A new colonoscopy skills assessment test improves both cognitive and motor skills, and suggests that 300 procedures is the threshold for advanced skill level.

Opioids appear to be associated with more adverse events among older adults with arthritis than other commonly used analgesics.

The clinical features of microscopic colitis may overlap with those of ulcerative colitis and other bowel conditions.

Issues of health literacy and numeracy come into play when identifying the best strategies for explaining the risk associated with treatments for IBD.

Several predictors may help clinicians determine which patients with IBD are at risk for more severe disease and potential complications.

Although treatment for IBD is expensive, adherence reduces hospitalizations, complications, and other factors that increase the cost of care.

Esophageal cancer risk in patients with GERD is not as pronounced as once thought; the rate in women is similar to that of breast cancer in men.

When IBD patients experience loss of response to therapy, the decision to escalate the dose or switch to other drugs depends on a number of factors.

What is the proper balance between mucosal healing and symptom control in treating patients with IBD?

Symptoms, not mucosal healing, should be the endpoint used in clinical practice to assess outcomes of patients with inflammatory bowel disease.

Novel biologics in development may provide alternatives to current standards of care in treating patients with refractory inflammatory bowel disease.

Adverse complications associated with IBD treatment may be uncommon, but awareness of these potential side effects is essential for proper management.

Defining, measuring, and tracking the care gastroenterologists provide to patients with IBD will improve the quality and consistency of care.

Most at-risk IBD patients have not received recommended vaccinations, even though 80% of these patients have visited their doctor in the last year.

Lessons learned in the management of children with IBD may help gastroenterologists improve the diagnosis and management of adults with the condition.

The Manchester Color Wheel helps determine which patients are most likely to respond to hypnotherapy, increasing the chances of success and reducing costs.

A Dartmouth computer model uses patient and disease characteristics to determine who will need the most aggressive therapies and who will do fine without them.

In 43 trials involving over 215,000 children, vitamin A supplements reduced risk of death from any cause by 24%, largely by preventing measles and diarrhea.

Low-dose aspirin enhances the fecal occult blood test's ability to detect advanced colorectal tumors, compared to no aspirin use.

New findings suggest that administering probiotics early in the course of diarrhea can reduce duration and prevent antibiotic-associated diarrhea in children.

Researchers at the University of East Anglia have developed a new endoscope to aid the early detection and diagnosis of inflammatory bowel disease.

Professor Francis Chan discusses the risks associated with taking NSAIDs for arthritis pain.

Nearly one in five patients suffering from Crohn's disease were found to have mental health status indicative of PTSD.

Ankylosing Spondylitis patients appear to be highly susceptible to Inflammatory Bowel Disease, including Crohn's disease.

Scheduling, registration, and other information for attendees of the 2010 Advances in Inflammatory Bowel Diseases, Clinical & Research Conference.